Ovarian cancer: Opportunity for targeted therapy

Tomoko Tagawa, Robert Morgan, Yun Yen, Joanne Mortimer

研究成果: 雜誌貢獻回顧型文獻同行評審

27 引文 斯高帕斯(Scopus)


Ovarian cancer is a common cause of cancer mortality in women with limited treatment effectiveness in advanced stages. The limitation to treatment is largely the result of high rates of cancer recurrence despite chemotherapy and eventual resistance to existing chemotherapeutic agents. The objective of this paper is to review current concepts of ovarian carcinogenesis. We will review existing hypotheses of tumor origin from ovarian epithelial cells, Fallopian tube, and endometrium. We will also review the molecular pathogenesis of ovarian cancer which results in two specific pathways of carcinogenesis: (1) type I low-grade tumor and (2) type II high-grade tumor. Improved understanding of the molecular basis of ovarian carcinogenesis has opened new opportunities for targeted therapy. This paper will also review these potential therapeutic targets and will explore new agents that are currently being investigated.

期刊Journal of Oncology
出版狀態已發佈 - 1月 13 2012

ASJC Scopus subject areas

  • 腫瘤科


深入研究「Ovarian cancer: Opportunity for targeted therapy」主題。共同形成了獨特的指紋。